• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

估计新 SARS-CoV-2 变体的选择强度。

Estimating the strength of selection for new SARS-CoV-2 variants.

机构信息

Theoretical Biology and Biophysics (T-6), Los Alamos National Laboratory, Los Alamos, NM, USA.

New Mexico Consortium, Los Alamos, NM, USA.

出版信息

Nat Commun. 2021 Dec 14;12(1):7239. doi: 10.1038/s41467-021-27369-3.

DOI:10.1038/s41467-021-27369-3
PMID:34907182
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8671537/
Abstract

Controlling the SARS-CoV-2 pandemic becomes increasingly challenging as the virus adapts to human hosts through the continual emergence of more transmissible variants. Simply observing that a variant is increasing in frequency is relatively straightforward, but more sophisticated methodology is needed to determine whether a new variant is a global threat and the magnitude of its selective advantage. We present two models for quantifying the strength of selection for new and emerging variants of SARS-CoV-2 relative to the background of contemporaneous variants. These methods range from a detailed model of dynamics within one country to a broad analysis across all countries, and they include alternative explanations such as migration and drift. We find evidence for strong selection favoring the D614G spike mutation and B.1.1.7 (Alpha), weaker selection favoring B.1.351 (Beta), and no advantage of R.1 after it spreads beyond Japan. Cutting back data to earlier time horizons reveals that uncertainty is large very soon after emergence, but that estimates of selection stabilize after several weeks. Our results also show substantial heterogeneity among countries, demonstrating the need for a truly global perspective on the molecular epidemiology of SARS-CoV-2.

摘要

随着病毒通过不断出现更具传染性的变种来适应人类宿主,控制 SARS-CoV-2 大流行变得越来越具有挑战性。简单地观察到一个变种的频率在增加相对来说比较简单,但需要更复杂的方法来确定新变种是否对全球构成威胁,以及其选择优势的大小。我们提出了两种模型,用于定量评估 SARS-CoV-2 的新出现变种相对于同时代变种的选择强度。这些方法的范围从一个国家内部的详细动态模型到所有国家的广泛分析,并且包括了迁移和漂移等替代解释。我们发现有证据表明 D614G 刺突突变和 B.1.1.7(Alpha)受到强烈选择,B.1.351(Beta)受到较弱选择,而 R.1 在传播到日本以外后没有优势。将数据缩短到更早的时间范围可以发现,在出现后不久,不确定性非常大,但选择的估计值在数周后稳定下来。我们的结果还显示了各国之间存在很大的异质性,这表明需要从真正的全球视角来研究 SARS-CoV-2 的分子流行病学。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65f7/8671537/a2ad0c5250cf/41467_2021_27369_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65f7/8671537/d98ca50b011b/41467_2021_27369_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65f7/8671537/a022dbf08a4f/41467_2021_27369_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65f7/8671537/368570da86b9/41467_2021_27369_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65f7/8671537/ea63b050b77c/41467_2021_27369_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65f7/8671537/9bcb8d772503/41467_2021_27369_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65f7/8671537/47434975d1ac/41467_2021_27369_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65f7/8671537/61c8dfd55048/41467_2021_27369_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65f7/8671537/a2ad0c5250cf/41467_2021_27369_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65f7/8671537/d98ca50b011b/41467_2021_27369_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65f7/8671537/a022dbf08a4f/41467_2021_27369_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65f7/8671537/368570da86b9/41467_2021_27369_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65f7/8671537/ea63b050b77c/41467_2021_27369_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65f7/8671537/9bcb8d772503/41467_2021_27369_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65f7/8671537/47434975d1ac/41467_2021_27369_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65f7/8671537/61c8dfd55048/41467_2021_27369_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65f7/8671537/a2ad0c5250cf/41467_2021_27369_Fig8_HTML.jpg

相似文献

1
Estimating the strength of selection for new SARS-CoV-2 variants.估计新 SARS-CoV-2 变体的选择强度。
Nat Commun. 2021 Dec 14;12(1):7239. doi: 10.1038/s41467-021-27369-3.
2
Estimating the strength of selection for new SARS-CoV-2 variants.评估新型严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体的选择强度。
medRxiv. 2021 Sep 24:2021.03.29.21254233. doi: 10.1101/2021.03.29.21254233.
3
Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity.评估 SARS-CoV-2 刺突突变 D614G 对传染性和致病性的影响。
Cell. 2021 Jan 7;184(1):64-75.e11. doi: 10.1016/j.cell.2020.11.020. Epub 2020 Nov 19.
4
CRISPR-Cas12a-Based Detection for the Major SARS-CoV-2 Variants of Concern.基于 CRISPR-Cas12a 的主要关注 SARS-CoV-2 变体检测。
Microbiol Spectr. 2021 Dec 22;9(3):e0101721. doi: 10.1128/Spectrum.01017-21. Epub 2021 Nov 17.
5
V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.SARS-CoV-2 刺突 RBD 中的 V367F 突变增强了与人类 ACE2 受体的结合亲和力,从而提高了病毒的感染性。
J Virol. 2021 Jul 26;95(16):e0061721. doi: 10.1128/JVI.00617-21.
6
Transformations, Lineage Comparisons, and Analysis of Down-to-Up Protomer States of Variants of the SARS-CoV-2 Prefusion Spike Protein, Including the UK Variant B.1.1.7.SARS-CoV-2 前融合刺突蛋白变体的构象转变、谱系比较及从头至尾三聚体状态分析,包括英国 B.1.1.7 变体。
Microbiol Spectr. 2021 Sep 3;9(1):e0003021. doi: 10.1128/Spectrum.00030-21. Epub 2021 Aug 4.
7
The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 Variants.刺突蛋白稳定的 D614G 突变与 S1/S2 裂解位点突变相互作用,促进 SARS-CoV-2 变体的感染潜力。
J Virol. 2022 Oct 12;96(19):e0130122. doi: 10.1128/jvi.01301-22. Epub 2022 Sep 19.
8
Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics.常见突变对 SARS-CoV-2 刺突 RBD 及其配体人 ACE2 受体结合亲和力和动力学的影响。
Elife. 2021 Aug 26;10:e70658. doi: 10.7554/eLife.70658.
9
Spread of Gamma (P.1) Sub-Lineages Carrying Spike Mutations Close to the Furin Cleavage Site and Deletions in the N-Terminal Domain Drives Ongoing Transmission of SARS-CoV-2 in Amazonas, Brazil.携带接近弗林裂解位点的刺突突变和 N 端结构域缺失的伽马(P.1)亚谱系的传播推动了巴西亚马逊州 SARS-CoV-2 的持续传播。
Microbiol Spectr. 2022 Feb 23;10(1):e0236621. doi: 10.1128/spectrum.02366-21.
10
Impact of Genetic Variability in ACE2 Expression on the Evolutionary Dynamics of SARS-CoV-2 Spike D614G Mutation.ACE2 表达中的遗传变异性对 SARS-CoV-2 刺突 D614G 突变进化动态的影响。
Genes (Basel). 2020 Dec 24;12(1):16. doi: 10.3390/genes12010016.

引用本文的文献

1
CovTransformer: A transformer model for SARS-CoV-2 lineage frequency forecasting.CovTransformer:一种用于预测SARS-CoV-2谱系频率的变压器模型。
Virus Evol. 2024 Nov 14;10(1):veae086. doi: 10.1093/ve/veae086. eCollection 2024.
2
Early detection of highly transmissible viral variants using phylogenomics.利用系统发生基因组学早期检测高传染性病毒变体。
Sci Adv. 2024 Aug 16;10(33):eadk7623. doi: 10.1126/sciadv.adk7623. Epub 2024 Aug 14.
3
Estimation of SARS-CoV-2 fitness gains from genomic surveillance data without prior lineage classification.

本文引用的文献

1
Stan: A Probabilistic Programming Language.斯坦:一种概率编程语言。
J Stat Softw. 2017;76. doi: 10.18637/jss.v076.i01. Epub 2017 Jan 11.
2
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion.SARS-CoV-2 B.1.617.2 德尔塔变异株复制和免疫逃逸。
Nature. 2021 Nov;599(7883):114-119. doi: 10.1038/s41586-021-03944-y. Epub 2021 Sep 6.
3
Quantification of the spread of SARS-CoV-2 variant B.1.1.7 in Switzerland.瑞士关于 SARS-CoV-2 变异株 B.1.1.7 传播情况的定量分析。
基于基因组监测数据估计 SARS-CoV-2 的适应度增益,无需事先进行谱系分类。
Proc Natl Acad Sci U S A. 2024 Jun 18;121(25):e2314262121. doi: 10.1073/pnas.2314262121. Epub 2024 Jun 11.
4
Lineage frequency time series reveal elevated levels of genetic drift in SARS-CoV-2 transmission in England.谱系频率时间序列揭示了新冠病毒在英国传播过程中基因漂变水平的升高。
PLoS Pathog. 2024 Apr 15;20(4):e1012090. doi: 10.1371/journal.ppat.1012090. eCollection 2024 Apr.
5
The most exposed regions of SARS-CoV-2 structural proteins are subject to strong positive selection and gene overlap may locally modify this behavior.SARS-CoV-2 结构蛋白中暴露最多的区域受到强烈的正选择,基因重叠可能会局部改变这种行为。
mSystems. 2024 Jan 23;9(1):e0071323. doi: 10.1128/msystems.00713-23. Epub 2023 Dec 14.
6
Phylogenies increase power to detect highly transmissible viral genome variants.系统发育学增强了检测高传播性病毒基因组变异体的能力。
medRxiv. 2023 Aug 5:2023.07.28.23293332. doi: 10.1101/2023.07.28.23293332.
7
Enhancing global preparedness during an ongoing pandemic from partial and noisy data.利用不完整和有噪声的数据在持续的大流行期间加强全球防范能力。
PNAS Nexus. 2023 Jun 7;2(6):pgad192. doi: 10.1093/pnasnexus/pgad192. eCollection 2023 Jun.
8
Phylogenetic Changes in SARS-CoV-2 Virus in Bosnian-Herzegovinian Population Over the Period of Two Years.两年间波斯尼亚和黑塞哥维那人群中新冠病毒的系统发育变化
Acta Inform Med. 2023 Mar;31(1):57-61. doi: 10.5455/aim.2023.31.57-61.
9
SARS-CoV-2 variant transition dynamics are associated with vaccination rates, number of co-circulating variants, and convalescent immunity.SARS-CoV-2 变异株的传播动态与疫苗接种率、共同传播变异株的数量以及康复后的免疫能力有关。
EBioMedicine. 2023 May;91:104534. doi: 10.1016/j.ebiom.2023.104534. Epub 2023 Mar 31.
10
How public health authorities can use pathogen genomics in health protection practice: a consensus-building Delphi study conducted in the United Kingdom.公共卫生部门如何在卫生保护实践中利用病原体基因组学:在英国开展的一项共识构建德尔菲研究。
Microb Genom. 2023 Feb;9(2). doi: 10.1099/mgen.0.000912.
Epidemics. 2021 Dec;37:100480. doi: 10.1016/j.epidem.2021.100480. Epub 2021 Aug 9.
4
Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study.与关注的阿尔法(B.1.1.7)变体相比,感染新冠病毒德尔塔(B.1.617.2)变体的住院和急诊就诊风险:一项队列研究。
Lancet Infect Dis. 2022 Jan;22(1):35-42. doi: 10.1016/S1473-3099(21)00475-8. Epub 2021 Aug 27.
5
Emergence and expansion of SARS-CoV-2 B.1.526 after identification in New York.在纽约发现后,SARS-CoV-2 B.1.526 的出现和传播。
Nature. 2021 Sep;597(7878):703-708. doi: 10.1038/s41586-021-03908-2. Epub 2021 Aug 24.
6
Detection of R.1 lineage severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with spike protein W152L/E484K/G769V mutations in Japan.在日本检测到带有棘突蛋白 W152L/E484K/G769V 突变的 R.1 谱系严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)。
PLoS Pathog. 2021 Jun 7;17(6):e1009619. doi: 10.1371/journal.ppat.1009619. eCollection 2021 Jun.
7
SARS-CoV-2 variants of concern are emerging in India.令人担忧的新冠病毒变异毒株正在印度出现。
Nat Med. 2021 Jul;27(7):1131-1133. doi: 10.1038/s41591-021-01397-4.
8
Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study.英国伦敦出现的 SARS-CoV-2 B.1.1.7 谱系的基因组特征和临床效果:全基因组测序和基于医院的队列研究。
Lancet Infect Dis. 2021 Sep;21(9):1246-1256. doi: 10.1016/S1473-3099(21)00170-5. Epub 2021 Apr 12.
9
Concerns about SARS-CoV-2 evolution should not hold back efforts to expand vaccination.对 SARS-CoV-2 进化的担忧不应阻碍疫苗接种工作的开展。
Nat Rev Immunol. 2021 May;21(5):330-335. doi: 10.1038/s41577-021-00544-9. Epub 2021 Apr 1.
10
Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7.社区检出的 SARS-CoV-2 谱系 B.1.1.7 病例死亡率增加。
Nature. 2021 May;593(7858):270-274. doi: 10.1038/s41586-021-03426-1. Epub 2021 Mar 15.